Patch Study

Study Number: C21-D015

Study Location: 

Dallas Research Center: 1801 N. Glenville Dr., Suite 250 Richardson, Texas 75081
Compensation: $300

Gender:

Females

Age:

18-45

Skin Type:

I-VI

Study Requirements:

  • Must be willing to attend all 14 visits.
  • Cannot be currently using topical steroids and/or drugs on the test sites.
  • Cannot have atopic skin disease, active or history of psoriasis, or active eczema.
  • Cannot have been diagnosed with known allergies to skin care products, including adhesives and/or cyanoacrylate (Super Glue) or ingredients of the test materials.
  • Cannot be breastfeeding, pregnant, or planning to become pregnant during the study
  • Cannot be currently or frequently using prescription-strength anti-inflammatory drugs or high doses of anti-inflammatory drugs for a defined medical condition as determined by the initial paperwork. Low dose aspirin (≤81mg per day) is acceptable.
  • Must not have observable birthmarks, moles, vitiligo, keloids, sunburn, suntan, scar tissue, nevi, excessive hair, tattoos, or other dermal conditions on the back.
  • Cannot have active hepatitis, acute or chronic renal insufficiency
  • Cannot have a health condition and/or pre-existing or dormant dermatologic disease on the back (eg, rosacea, severe acne, acne conglobata, nodules, or cysts, seborrheic dermatitis, severe excoriations)
  • Using topical steroids and/or drugs at the test sites
  • Currently or frequently using prescription-strength anti-inflammatory drugs or high doses of anti-inflammatory drugs for a defined medical condition as determined by the initial paperwork. Low dose aspirin (≤81mg per day) is acceptable.
  • Having observable birthmarks, moles, vitiligo, keloids, sunburn, suntan, scar tissue, nevi, excessive hair, tattoos, or other dermal conditions on the back that might influence the test results in the opinion of the Investigator or designee.
  • During the eligibility screening, individuals who indicate that they have previously had eczema will be advised of the Koebner phenomenon, which refers to the appearance of these conditions either at the patch site or unrelated sites. If the individual chooses to participate in the study, an original signed supplemental consent for each subject participating in the study will be retained in the study file, and each subject will receive a copy of the signed supplemental consent.
  • Cannot currently be participating in another study at SGS Stephens, another research facility or doctor’s office
  • Cannot have participated on a study at SGS Stephens, another research facility or doctor’s office involving the back within the past 2 weeks.
  • What is Fitzpatrick Skin Type? Determine your Fitzpatrick Skin Type Here!

Fill out the fields below to apply!

Please note: You must be using Safari, Firefox or Chrome to apply.

All information you provide will be kept confidential, you may be contacted by telephone, and your information may be added to a database.

By applying for this study at our Facility in Dallas, Texas, you confirm that you are able and willing to travel to its location.

Application Form